One MRI scan to rule them all? new study tests organ health in diabetes
NCT ID NCT04137705
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a single, standardized MRI scan can reliably measure body composition and the health of multiple organs—like the liver, pancreas, heart, and kidneys—in people with type 2 diabetes and healthy volunteers. 43 participants were scanned twice on the same machine and on different machines to check how repeatable the measurements were. The goal was to see if this approach could be a useful tool for future research or clinical care, not to treat the disease itself.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this MRI method could help doctors better understand how type 2 diabetes affects multiple organs, potentially leading to earlier detection or monitoring.
What could go wrong
This is a small, early-stage study focused on measuring reproducibility, not on treating or curing diabetes. The results may not apply to all patients or scanners.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beaver House
Oxford, OX1 2EH, United Kingdom
-
Gemini One
Oxford, OX4 2LL, United Kingdom
-
Oxford Centre for Magnetic Resonance
Oxford, OX3 9DU, United Kingdom